Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

2.300

-0.070 (-2.95%)

May 14, 2025, 11:07 AM - Market open

Vistagen Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	May '25 May 14, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2015 - 2019
Market Capitalization	66	143	27	256	305	22	Upgrade
Market Cap Growth	-40.87%	421.73%	-89.32%	-16.12%	1309.99%	-60.31%	Upgrade
Enterprise Value	-18	18	5	176	211	29	Upgrade
Last Close Price	2.37	5.28	3.74	37.20	63.90	13.20	Upgrade
PS Ratio	103.96	134.11	-120.48	230.95	280.23	-	Upgrade
PB Ratio	0.83	1.25	2.26	3.96	3.11	-30.17	Upgrade
P/TBV Ratio	0.85	1.25	2.26	3.96	3.32	-	Upgrade
EV/Sales Ratio	-	17.28	-	158.30	193.50	-	Upgrade
Debt / Equity Ratio	0.02	0.02	0.22	0.05	0.04	-5.70	Upgrade
Asset Turnover	0.01	0.02	-	0.01	0.02	-	Upgrade
Quick Ratio	9.21	23.26	3.64	11.88	24.62	0.49	Upgrade
Current Ratio	9.35	23.56	3.83	12.32	24.86	0.57	Upgrade
Return on Equity (ROE)	-46.28%	-46.47%	-154.30%	-58.62%	-36.78%	-411.13%	Upgrade
Return on Assets (ROA)	-29.57%	-28.52%	-77.39%	-32.65%	-19.66%	-131.43%	Upgrade
Return on Capital (ROIC)	-31.70%	-31.46%	-89.75%	-35.19%	-21.28%	-182.29%	Upgrade
Earnings Yield	-68.89%	-20.58%	-216.63%	-18.65%	-5.87%	-95.94%	Upgrade
FCF Yield	-57.02%	-18.13%	-182.55%	-17.75%	-4.04%	-72.77%	Upgrade
Buyback Yield / Dilution	-126.55%	-178.13%	-5.45%	-129.85%	-96.34%	-53.59%	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q